Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Concordance of DMET plus genotyping results with those of orthogonal genotyping methods.

Fernandez CA, Smith C, Yang W, Lorier R, Crews KR, Kornegay N, Hicks JK, Stewart CF, Kawedia JD, Ramsey LB, Liu C, Evans WE, Relling MV, Broeckel U.

Clin Pharmacol Ther. 2012 Sep;92(3):360-5. doi: 10.1038/clpt.2012.95.

2.

High-quality genotyping data from formalin-fixed, paraffin-embedded tissue on the drug metabolizing enzymes and transporters plus array.

Vos HI, van der Straaten T, Coenen MJ, Flucke U, te Loo DM, Guchelaar HJ.

J Mol Diagn. 2015 Jan;17(1):4-9. doi: 10.1016/j.jmoldx.2014.08.003.

PMID:
25528187
3.

Assessing the utility of whole genome amplified DNA as a template for DMET Plus array.

He YJ, Misher AD, Irvin W Jr, Motsinger-Reif A, McLeod HL, Hoskins JM.

Clin Chem Lab Med. 2012 Feb 14;50(8):1329-34. doi: 10.1515/cclm-2011-0747.

PMID:
22868796
4.

Characterization of 137 Genomic DNA Reference Materials for 28 Pharmacogenetic Genes: A GeT-RM Collaborative Project.

Pratt VM, Everts RE, Aggarwal P, Beyer BN, Broeckel U, Epstein-Baak R, Hujsak P, Kornreich R, Liao J, Lorier R, Scott SA, Smith CH, Toji LH, Turner A, Kalman LV.

J Mol Diagn. 2016 Jan;18(1):109-23. doi: 10.1016/j.jmoldx.2015.08.005.

5.

Comparison of genetic variation in drug ADME-related genes in Thais with Caucasian, African and Asian HapMap populations.

Jittikoon J, Mahasirimongkol S, Charoenyingwattana A, Chaikledkaew U, Tragulpiankit P, Mangmool S, Inunchot W, Somboonyosdes C, Wichukchinda N, Sawanpanyalert P, He Y, McLeod HL, Chantratita W.

J Hum Genet. 2016 Feb;61(2):119-27. doi: 10.1038/jhg.2015.115.

PMID:
26423926
6.

Genotype and allele frequencies of drug-metabolizing enzymes and drug transporter genes affecting immunosuppressants in the Spanish white population.

Bosó V, Herrero MJ, Buso E, Galán J, Almenar L, Sánchez-Lázaro I, Sánchez-Plumed J, Bea S, Prieto M, García M, Pastor A, Sole A, Poveda JL, Aliño SF.

Ther Drug Monit. 2014 Apr;36(2):159-68. doi: 10.1097/FTD.0b013e3182a94e65.

PMID:
24232128
7.

Genotyping performance between saliva and blood-derived genomic DNAs on the DMET array: a comparison.

Hu Y, Ehli EA, Nelson K, Bohlen K, Lynch C, Huizenga P, Kittlelsrud J, Soundy TJ, Davies GE.

PLoS One. 2012;7(3):e33968. doi: 10.1371/journal.pone.0033968.

8.

Genotyping of CYP2C19 polymorphisms and its clinical validation in the ethnic Arab population.

Tayeb HT, Bakheet DH, Zaza K, Wakil SM, Dzimiri N.

J Pharm Pharmacol. 2015 Jul;67(7):972-9. doi: 10.1111/jphp.12391. Retraction in: J Pharm Pharmacol. 2016 Mar;68(3):421.

PMID:
25684066
9.

Genotyping of the cytochrome P450 2D6 4469 C>T polymorphism using SimpleProbes.

Nielsen KA, Hansen EL, Gille S.

Scand J Clin Lab Invest. 2007;67(3):280-90.

PMID:
17454842
10.

DMET microarray technology for pharmacogenomics-based personalized medicine.

Burmester JK, Sedova M, Shapero MH, Mansfield E.

Methods Mol Biol. 2010;632:99-124. doi: 10.1007/978-1-60761-663-4_7.

PMID:
20217574
11.

GenoChip CYP2D6 macroarray as a method to genotype for CYP2D6 variants: results of a validation study in a Caucasian population.

Bank PC, Swen JJ, Guchelaar HJ, van der Straaten T.

Pharmacogenomics. 2015;16(7):681-7. doi: 10.2217/pgs.15.30.

PMID:
25929855
12.

The limits of genome-wide methods for pharmacogenomic testing.

Gamazon ER, Skol AD, Perera MA.

Pharmacogenet Genomics. 2012 Apr;22(4):261-72. doi: 10.1097/FPC.0b013e328350ca5f.

13.

A pharmacogenetic study of docetaxel and thalidomide in patients with castration-resistant prostate cancer using the DMET genotyping platform.

Deeken JF, Cormier T, Price DK, Sissung TM, Steinberg SM, Tran K, Liewehr DJ, Dahut WL, Miao X, Figg WD.

Pharmacogenomics J. 2010 Jun;10(3):191-9. doi: 10.1038/tpj.2009.57.

PMID:
20038957
14.

TaqMan® drug metabolism genotyping assays for the detection of human polymorphisms involved in drug metabolism.

Hartshorne T.

Methods Mol Biol. 2013;1015:87-96. doi: 10.1007/978-1-62703-435-7_5.

PMID:
23824850
15.

High concordance of bovine single nucleotide polymorphism genotypes generated using two independent genotyping strategies.

Magee DA, Berkowicz EW, Sikora KM, Sweeney T, Kenny DA, Kelly AK, Evans RD, Wickham BW, Bradley DG, Spillane C, MacHugh DE.

Anim Biotechnol. 2010 Oct;21(4):257-62. doi: 10.1080/10495398.2010.509680.

PMID:
20967645
16.

PG4KDS: a model for the clinical implementation of pre-emptive pharmacogenetics.

Hoffman JM, Haidar CE, Wilkinson MR, Crews KR, Baker DK, Kornegay NM, Yang W, Pui CH, Reiss UM, Gaur AH, Howard SC, Evans WE, Broeckel U, Relling MV.

Am J Med Genet C Semin Med Genet. 2014 Mar;166C(1):45-55. doi: 10.1002/ajmg.c.31391.

17.

Korean, Japanese, and Chinese populations featured similar genes encoding drug-metabolizing enzymes and transporters: a DMET Plus microarray assessment.

Yi S, An H, Lee H, Lee S, Ieiri I, Lee Y, Cho JY, Hirota T, Fukae M, Yoshida K, Nagatsuka S, Kimura M, Irie S, Sugiyama Y, Shin DW, Lim KS, Chung JY, Yu KS, Jang IJ.

Pharmacogenet Genomics. 2014 Oct;24(10):477-85. doi: 10.1097/FPC.0000000000000075.

PMID:
25029633
18.

Estimation of the rate of SNP genotyping errors from DNA extracted from different tissues.

Montgomery GW, Campbell MJ, Dickson P, Herbert S, Siemering K, Ewen-White KR, Visscher PM, Martin NG.

Twin Res Hum Genet. 2005 Aug;8(4):346-52.

PMID:
16176719
19.

Hot topic: performance of bovine high-density genotyping platforms in Holsteins and Jerseys.

Rincon G, Weber KL, Eenennaam AL, Golden BL, Medrano JF.

J Dairy Sci. 2011 Dec;94(12):6116-21. doi: 10.3168/jds.2011-4764.

PMID:
22118099
20.

Role of CYP450 in pharmacokinetics and pharmacogenetics of antihypertensive drugs.

Rodríguez Arcas MJ, García-Jiménez E, Martínez-Martínez F, Conesa-Zamora P.

Farm Hosp. 2011 Mar-Apr;35(2):84-92. doi: 10.1016/j.farma.2010.05.006. Review. English, Spanish.

PMID:
21093338

Supplemental Content

Support Center